8-K//Current report
Eloxx Pharmaceuticals, Inc. 8-K
Accession 0001104659-24-109521
CIK 0001035354operating
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:01 PM ET
Size
288.6 KB
Accession
0001104659-24-109521
Documents
- 8-Ktm2426349d1_8k.htmPrimary
FORM 8-K
- EX-10.1tm2426349d1_ex10-1.htm
EXHIBIT 10.1
- EX-101.SCHelox-20241016.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABelox-20241016_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREelox-20241016_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-24-109521-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLtm2426349d1_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001035354
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:01 PM ET
- Size
- 288.6 KB